Prognostic Value of CV Biomarkers, End Points in Cancer Screening Trials, USPSTF on Breast Cancer Screening, and more
JAMA Editors' Summary06/11/24 • 12 min
Editor’s Summary by Mary McGrae McDermott, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the June 11, 2024, issue.
06/11/24 • 12 min
Generate a badge
Get a badge for your website that links back to this episode
Select type & size
<a href="https://goodpods.com/podcasts/jama-editors-summary-117658/prognostic-value-of-cv-biomarkers-end-points-in-cancer-screening-trial-54076520"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to prognostic value of cv biomarkers, end points in cancer screening trials, uspstf on breast cancer screening, and more on goodpods" style="width: 225px" /> </a>
Copy